Anterix walks into its June 11 quarterly results carrying an awkward combination: a stock up 15% in a month, short interest near 9% of the float, and a fresh downgrade from the firm that had been its most vocal public supporter.
The analyst move is the standout this week. B. Riley Securities downgraded Anterix to Neutral on June 4 — less than a week before earnings — while simultaneously raising its price target from $44 to $69. That's a telling split: the analyst is marking the stock up to reflect where it has traded, but stepping back from the conviction call. With the consensus sitting at just one buy and one hold, the Street is thin and now tilted more cautious. The mean price target of roughly $64 is barely above the current price of $64.55, leaving almost no implied upside in the formal coverage. The ORTEX short score has edged higher through the week to 61.3, consistent with a position that is neither extremely crowded nor particularly relaxed.
Short interest tells a story of modest but real pressure. At 8.9% of the free float — roughly 1.67 million shares — it is not a squeeze-risk level, but it is meaningful for a name this thinly covered. The 90-day change shows shorts building by about 5%, even as the past week saw a small unwind of around 2%. Borrow remains cheap at 0.53%, barely changed, and availability is ample at 367% — meaning there are roughly three-and-a-half shares available to borrow for every one already lent out. That keeps the short trade accessible with no pressure on lenders. Options positioning meanwhile leans strongly bullish: the put/call ratio of 0.13 is near the bottom of its 52-week range and slightly below its 20-day average, suggesting call demand is still running well above put demand heading into the print. The divergence between a rising short position and call-heavy options flow captures the disagreement in the market cleanly.
What bulls and bears are debating is essentially a question of timing. Anterix's value proposition rests on monetising its 900 MHz spectrum holdings through long-term utility sector contracts — a thesis that has been in development for years with limited revenue to show. The stock's momentum scores are exceptional, ranking near the top of the universe on relative strength, but quality metrics are deeply negative: ORTEX factor data shows a short score rank in just the 7th percentile, ROA and ROCE are both negative, and the EV/EBITDA multiple of roughly -20x reflects a pre-revenue structure. The ownership base is concentrated, with Owl Creek Asset Management holding nearly 29% and Heard Capital another 9%. Neither changed their position materially in the most recent filings, which signals conviction but also concentration risk.
The insider picture adds a modest complication. Through May, the CFO and Chief Legal Officer each made small sales at prices in the high $50s — routine in size, with trade significance scores of 1, but worth noting given the pace of the stock's move. The CEO bought shares in late 2025 at prices around $20-21, a reminder of how far the stock has run from those levels, and also how old that buy signal now is.
The earnings print scheduled for June 11 is the immediate focus: the prior quarterly result produced a 7% one-day gain and a 16% five-day move, so the market has been willing to reward positive news sharply. Whether the Street's newly cautious tone and the still-elevated short position act as a brake or a coiled spring on any announcement will define the next phase of the trade.
See the live data behind this article on ORTEX.
Open ATEX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
